Impact of Body Mass Index on Renal Function Impairment in Patients Treated for Renal Cell Carcinoma at High Risk of Recurrence: Key Implications for Systemic Therapy Eligibility
Urologia Internationalis · 2025
DOI: 10.1159/000549603 ↗Kurz gefasst
Fachartikel in der Zeitschrift Urologia Internationalis, 2025. Verfasst von Pietro Scilipoti und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Experimental Oncology/Unit of Urology, IRCCS Ospedale San Raffaele, Milan, Italy, scilipoti.pietro@hsr.it. Hauptthemen laut MEDLINE: Body Mass Index, Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasm Recurrence, Local. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Introduction
Adjuvant or salvage systemic therapy after nephrectomy for intermediate- and high-risk clear cell renal cell carcinoma (ccRCC) improves overall survival. However, severe renal impairment represents a relative contraindication to systemic therapy administration. This study aimed to analyze the impact of overweight and obesity at the time of nephrectomy in determining subsequent renal function impairment and limited accessibility to systemic therapy.
Methods
Within a prospectively maintained database, we identified 795 nonmetastatic ccRCC patients at intermediate or high risk of recurrence. BMI was calculated as weight/height (kg/m2), and chronic kidney disease (CKD) upstage was defined as estimated glomerular filtration rate
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Experimental Oncology/Unit of Urology, IRCCS Ospedale San Raffaele, Milan, Italy, scilipoti.pietro@hsr.it.
- Vita-Salute San Raffaele University, Milan, Italy, scilipoti.pietro@hsr.it.
- Division of Experimental Oncology/Unit of Urology, IRCCS Ospedale San Raffaele, Milan, Italy.
- Vita-Salute San Raffaele University, Milan, Italy.
- Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Québec, Canada.
- Department of Urology, Onze-Lieve-Vrouwziekenhuis, Aalst, Belgium.
Zitieren
APA
Scilipoti, P., Rosiello, G., Longoni, M., Bettiga, A., Re, C., Musso, G., Cei, F., Salerno, L., Belladelli, F., Karakiewicz, P. I., Mottrie, A., Briganti, A., Salonia, A., Mercinelli, C., Cigliola, A., Necchi, A., Trevisani, F., Montorsi, F., Larcher, A., & Capitanio, U. (2025). Impact of Body Mass Index on Renal Function Impairment in Patients Treated for Renal Cell Carcinoma at High Risk of Recurrence: Key Implications for Systemic Therapy Eligibility. Urologia Internationalis. https://doi.org/10.1159/000549603
Vancouver
Scilipoti P, Rosiello G, Longoni M, Bettiga A, Re C, Musso G, et al. Impact of Body Mass Index on Renal Function Impairment in Patients Treated for Renal Cell Carcinoma at High Risk of Recurrence: Key Implications for Systemic Therapy Eligibility. Urologia Internationalis. 2025. doi:10.1159/000549603
BibTeX
@article{Scilipoti2025,
author = {Scilipoti, Pietro and Rosiello, Giuseppe and Longoni, Mattia and Bettiga, Arianna and Re, Chiara and Musso, Giacomo and Cei, Francesco and Salerno, Lucia and Belladelli, Federico and Karakiewicz, Pierre I and Mottrie, Alexandre and Briganti, Alberto and Salonia, Andrea and Mercinelli, Chiara and Cigliola, Antonio and Necchi, Andrea and Trevisani, Francesco and Montorsi, Francesco and Larcher, Alessandro and Capitanio, Umberto},
title = {Impact of Body Mass Index on Renal Function Impairment in Patients Treated for Renal Cell Carcinoma at High Risk of Recurrence: Key Implications for Systemic Therapy Eligibility},
journal = {Urologia Internationalis},
year = {2025},
doi = {10.1159/000549603}
}
EUVIMED